BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 12244890)

  • 21. Ginkgo biloba.
    Sierpina VS; Wollschlaeger B; Blumenthal M
    Am Fam Physician; 2003 Sep; 68(5):923-6. PubMed ID: 13678141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?
    Ramassamy C; Longpré F; Christen Y
    Curr Alzheimer Res; 2007 Jul; 4(3):253-62. PubMed ID: 17627482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
    Schulz V
    Phytomedicine; 2003; 10 Suppl 4():74-9. PubMed ID: 12807348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Ginkgo biloba extract EGb 761 ® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials.
    Ihl R
    Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():8-14. PubMed ID: 23808613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [External validity of clinical trials for treatment of dementia with ginkgo biloba extracts].
    Bornhöft G; Maxion-Bergemann S; Matthiessen PF
    Z Gerontol Geriatr; 2008 Aug; 41(4):298-312. PubMed ID: 18327688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.
    Nasab NM; Bahrammi MA; Nikpour MR; Rahim F; Naghibis SN
    J Pak Med Assoc; 2012 Jul; 62(7):677-80. PubMed ID: 23866514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Gauthier S; Schlaefke S
    Clin Interv Aging; 2014; 9():2065-77. PubMed ID: 25506211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
    Napryeyenko O; Borzenko I;
    Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of Ginkgo biloba extract.
    Ahlemeyer B; Krieglstein J
    Cell Mol Life Sci; 2003 Sep; 60(9):1779-92. PubMed ID: 14523543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.
    Maurer K; Ihl R; Dierks T; Frölich L
    J Psychiatr Res; 1997; 31(6):645-55. PubMed ID: 9447569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia.
    García-Alberca JM; Mendoza S; Gris E
    Clin Drug Investig; 2022 May; 42(5):391-402. PubMed ID: 35349093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis.
    Charemboon T; Jaisin K
    J Med Assoc Thai; 2015 May; 98(5):508-13. PubMed ID: 26058281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
    Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
    Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.
    Weinmann S; Roll S; Schwarzbach C; Vauth C; Willich SN
    BMC Geriatr; 2010 Mar; 10():14. PubMed ID: 20236541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
    JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmaco-economic evaluation of Ginkgo special extract EGb 761 for dementias in Austria].
    Hörr R; Kieser M
    Wien Med Wochenschr; 2002; 152(15-16):427-31. PubMed ID: 12244892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2015; 43(2):589-603. PubMed ID: 25114079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
    Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
    Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginkgo might not be a brain saver.
    Consum Rep; 2009 Mar; 74(3):14. PubMed ID: 19309768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.